A phase IIa study of MPC 3100 in patients with acute myeloid leukaemia.
Phase of Trial: Phase II
Latest Information Update: 11 May 2012
At a glance
- Drugs MPC 3100 (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Myrexis
- 11 May 2012 Status changed from planning to suspended.
- 24 Nov 2011 New trial record